INTRODUCTION
============

Genetic analyses of the developmental processes in model organisms have elucidated the mechanisms of human diseases. The vertebrate pancreas is a model organ for dissecting the signaling pathways that are common to development and cancer. The genetic control of cell division and growth in exocrine pancreatic epithelia is crucial for ductal and acinar morphogenesis, and is directly relevant to the initiation and progression of malignant neoplasia during pancreatic tumorigenesis. However, the regulatory mechanisms involved in the control of the growth and thus the size of the exocrine pancreas are still poorly understood.

Understanding the mechanisms that regulate pancreatic development has been facilitated by studies in model organisms, including zebrafish (*Danio rerio*). The exocrine component of the zebrafish pancreas arises from endodermal progenitor cells that migrate from the gut tube, requiring the transcriptional activities of pancreatic and duodenal homeobox (Pdx1) and pancreas-specific transcription factor (Ptf1a) ([@b48-0040240]; [@b5-0040240]; [@b24-0040240]; [@b53-0040240]; [@b47-0040240]; [@b42-0040240]). Signaling pathways, including wingless-type mouse mammary tumor virus integration site family members (Wnt), fibroblast growth factor (Fgf) and sonic hedgehog (Shh), are implicated in the induction and patterning of exocrine pancreatic tissues ([@b19-0040240]; [@b25-0040240]; [@b11-0040240]; [@b8-0040240]). Differentiation of the exocrine pancreatic progenitors into acinar and ductal cells involves the complex interactions of Ptf1a, Pdx1, Fgf10 and Notch ([@b48-0040240]; [@b16-0040240]; [@b24-0040240]; [@b53-0040240]; [@b47-0040240]; [@b11-0040240]; [@b12-0040240]) (for a review, see [@b47-0040240]; [@b38-0040240]; [@b46-0040240]). During morphogenesis, the exocrine pancreatic epithelial cells proliferate and form the zymogen-granule-secreting acini and the highly branched ductal system ([@b47-0040240]). Whereas Notch is required for proliferation of pancreatic progenitors ([@b15-0040240]; [@b47-0040240]), optimal activity of RNA polymerase III is crucial for normal epithelial proliferation that is coordinately regulated with acinar and ductal morphogenesis ([@b47-0040240]; [@b50-0040240]; [@b46-0040240]). Although the molecular mechanisms underlying maintenance and regeneration of β-cells in pancreatic islets have been intensively studied, genetic control of the exocrine pancreatic growth that is directly relevant to cancer is still largely unexplored.

Ion channels control diverse cellular processes and physiological functions during embryogenesis and in adult life, but little is known about their roles in pancreatic development and cancer. The transient receptor potential (TRP) family is a superfamily of cation channels ([@b39-0040240]), and TRPM7 is member 7 of the melastatin-like subfamily. TRPM7 is a widely expressed divalent cation channel with protein serine/threonine kinase activity, and it regulates cellular Mg^2+^ and Ca^2+^ homeostasis ([@b28-0040240]; [@b32-0040240]; [@b35-0040240]). The kinase of TRPM7 can autophosphorylate, and its activity is regulated by Mg^2+^-ATP ([@b37-0040240]; [@b33-0040240]; [@b26-0040240]; [@b10-0040240]). At the cellular level, TRPM7 regulates survival of lymphocytes, neurons and mast cells ([@b28-0040240]; [@b1-0040240]; [@b45-0040240]), proliferation and migration of osteoblasts ([@b2-0040240]; [@b3-0040240]), and volume regulation of cervical and renal epithelia ([@b29-0040240]). During embryogenesis, TRPM7 is required for normal development of melanoblasts, osteoblasts and lymphocytes ([@b14-0040240]; [@b27-0040240]; [@b21-0040240]). Electrophysiological studies suggest that Mg^2+^ influx through the TRPM7 channel leads to altered intracellular levels of Ca^2+^, which elicits the various cellular responses of TRPM7 ([@b1-0040240]; [@b35-0040240]; [@b43-0040240]). However, the mechanisms that mediate the functions of TRPM7 in vertebrate organogenesis are poorly understood. The role of TRPM7 in the development of the exocrine pancreas has been unknown.

A variety of zebrafish mutations have identified roles of genes that regulate organogenesis, including that of the exocrine pancreas ([@b46-0040240]). The *sweetbread* (*swd*) mutation was recovered from an ethylnitrosourea-induced genome-wide mutagenesis screen because the mutants had relatively small exocrine pancreas ([@b47-0040240]). The *swd* mutants develop hypoplasia of pancreatic acini and hypomorphic branching of pancreatic ducts, as well as skin hypopigmentation ([@b47-0040240]). Pancreatic cell fate specification and cytodifferentiation are unaffected by the *swd* mutations ([@b47-0040240]). These data suggest that the *swd* mutations primarily affect proliferation of exocrine pancreatic epithelia and, consequently, affect acinar and ductal morphogenesis. Identification of the gene affected by the *swd* mutation and the functional roles of the *swd*-locus-encoded protein is expected to advance our knowledge of the genetic regulation of exocrine pancreatic growth.

In this study, we present evidence that the *swd* locus encodes *trpm7*, the zebrafish ortholog of mammalian *TRPM7*. The *swd* mutation reduced exocrine pancreatic epithelial proliferation by impairing progression of cell division cycle and cell growth. The exocrine pancreatic phenotype of the *swd* and *trpm7^b508^* mutants was partially rescued by supplementary Mg^2+^, with downregulation of *p21^cdkn1a^* and *cyclin-G1* mRNA levels. Expression of *suppressor of cytokine signaling 3a* (*socs3a*) was elevated in the *swd* and *trpm7^b508^* mutants, and repression of *socs3a* by supplementary Mg^2+^ or by antisense oligonucleotides improved exocrine pancreatic epithelial cell division and cell growth. *TRPM7* was overexpressed in human pancreatic adenocarcinoma tissues and cell lines. RNA-interference-mediated silencing of *TRPM7* impaired proliferation of pancreatic adenocarcinoma cells by arresting the cells in the G0-G1 phases of the cell cycle, and supplementary Mg^2+^ reversed these effects. These data indicate that Trpm7 plays a role in exocrine pancreatic proliferation and morphogenesis by the Mg^2+^-sensitive pathways that involve Socs3a in zebrafish, and they support a contributory role of TRPM7 in the pathogenesis of human pancreatic adenocarcinoma.

RESULTS
=======

The zebrafish *swd* mutations cause pancreatic acinar and ductal hypoplasia by impairing epithelial cell-cycle progression and growth
-------------------------------------------------------------------------------------------------------------------------------------

The two *swd* mutant lines (*swd^p75fm^* and *swd^p82mf^*) develop relatively small exocrine pancreas and have hypopigmented skin, and these two lines do not complement with each other, suggesting that they represent alleles of the same gene ([@b47-0040240]) ([Fig. 1A--I](#f1-0040240){ref-type="fig"}). In the *swd* mutants at 5 days post-fertilization (dpf), the pancreatic ducts were hypomorphic with reduced branching, and the pancreatic acini were diminished in size. The mutant acinar cells expressed carboxypeptidase A (Cpa), were reduced in size and expressed relatively few zymogen granules ([@b47-0040240]) ([Fig. 1J,K](#f1-0040240){ref-type="fig"}). The pancreatic islets of the *swd* mutants were indistinguishable from those of wild type (WT) as indicated by immunohistochemistry using anti-insulin and anti-glucagon antibodies (N.S.Y., unpublished).

![**The zebrafish *swd^p75fm^* and *swd^p82mf^* mutations cause exocrine pancreatic hypoplasia and reduced skin pigmentation.** (A--F) Bright-field images of the *swd* mutants and wild-type (wt) larvae. Green arrows point to pigmented skin. (G--I) Exocrine pancreas (red arrows) revealed by whole-mount in situ hybridization using anti-*trypsin* riboprobes. (J,K) Histological transverse sections of exocrine pancreas following immunohistochemistry using anti-Cpa antibodies. Staining with DAPI was used to visualize the nuclei. The histological sections are oriented as indicated: d, dorsal; v, ventral; r, right; l, left. (L,M) Exocrine pancreas (red arrows) revealed by whole-mount in situ hybridization using anti-*ptf1a* riboprobes. (N,O) Sagittal histological sections of larvae. e.p., exocrine pancreas; i, intestine; l, liver. (G,L) wt larvae were grown in E3 medium supplemented with PTU, which inhibits skin pigmentation, in order to facilitate visualization of the exocrine pancreas expressing *trypsin* or *ptf1a*. Note that the larvae shown in A--O were analyzed on 5 dpf. (A--C,G--I,L--O) The larvae are positioned in the same orientation and viewed from the right lateral side. (D--F) The views are in the dorsoventral direction.](DMM004564F1){#f1-0040240}

The pancreatic phenotype of the *swd* mutants was further characterized by examining the expression of the basic helix-loop-helix transcription factor *ptf1a* as a marker of exocrine pancreatic progenitors. As indicated by in situ hybridization, *ptf1a* mRNA was expressed in the exocrine pancreas of the *swd* mutants at 5 dpf, but the region of expression was reduced compared with WT ([Fig. 1L,M](#f1-0040240){ref-type="fig"}). This suggests that the *swd* mutation primarily affects proliferation of exocrine pancreatic progenitors, without affecting their cell fate specification and cytodifferentiation. The effect of the *swd* mutation is specific to the exocrine pancreas and skin (hypopigmentation), because the other digestive organs, including intestine and liver, of the *swd* mutants seem grossly normal on histological sections ([Fig. 1N,O](#f1-0040240){ref-type="fig"}). Consistent with the growth defect of exocrine pancreas and the skin hypopigmentation, the mRNA levels of the exocrine pancreatic enzymes were reduced by as much as 682% (chymotrypsinogen B1) in the *swd^p75fm^* mutants; that of the melanin precursor, *dopachrome tautomerase* (*dct*), was reduced by 157%, as revealed by transcriptional profiling at 72 hpf (supplementary material Table S1).

The proliferative ability of exocrine pancreatic epithelial cells in the *swd* mutants was then examined for cell-cycle progression and cell growth. The proportion of epithelial cells in the S phase of the cell cycle was determined using 5-bromo-2′-deoxyuridine (BrdU) as a marker ([Fig. 2A](#f2-0040240){ref-type="fig"}). Cell size as an indicator of growth was analyzed by morphometric determination of the surface area per cell ([Fig. 2B](#f2-0040240){ref-type="fig"}). In the exocrine pancreas of the *swd^p75fm^* mutants, the mean proportion of nuclei that was immunoreactive for BrdU was significantly reduced, as compared with WT (28% vs 40%, respectively). This indicates that the ability of exocrine pancreatic epithelial cells to enter into S phase is impaired in *swd^p75fm^* mutants. Similarly, in *swd^p75fm^* mutants, the mean exocrine pancreatic epithelial cell growth at 3 dpf and 5 dpf (119 and 180 μm^2^/cell, respectively) was significantly lower than that in WT (176 and 456 μm^2^/cell, respectively). This suggests that exocrine pancreatic epithelial cell growth in the *swd* mutants is reduced and retarded. There was no increased apoptotic cell death in exocrine pancreas of either *swd* mutants or WT larvae at 3--5 dpf using the Apoptag assay (N.S.Y., unpublished). Taken together, these results suggest that the *swd*-locus-encoded protein is required for cell-cycle progression and growth of the exocrine pancreatic epithelia during morphogenesis.

![**The *swd^p75fm^* mutation impairs exocrine pancreatic epithelial cell division and cell growth.** (A) Cell-cycle analysis of the exocrine pancreatic epithelia in *swd^p75fm^* mutants and WT siblings at 72 hpf. % BrdU+ nuclei represent the proportion of cells in the S phase of the cell cycle. (B) Morphometric analysis of cell growth (area, in μm^2^, per cell) in the exocrine pancreatic epithelia of *swd^p75fm^* mutants and WT siblings on 3 and 5 dpf. Each value represents the mean + s.e.m. Statistical analysis was performed using Student's *t*-test, with \**P*\<0.05 considered statistically significant.](DMM004564F2){#f2-0040240}

The *swd* locus encodes the zebrafish ortholog of mammalian TRPM7
-----------------------------------------------------------------

Using positional cloning techniques, we identified *trpm7* as a candidate gene being affected by the *swd* mutations. The zebrafish mutation *touchtone* (*tct*) affects *trpm7* ([@b14-0040240]) and it has been shown to cause skin hypopigmentation with normal retinal pigment, which is similar to the *swd* mutants. The alleles of *tct*, *trpm7^j124e1^* and *trpm7^b508^* have premature stop codons that lead to deletion of the kinase domain in Trpm7 ([@b14-0040240]). To investigate whether exocrine pancreas is also affected, the *trpm7^j124e1^* and *trpm7^b508^* mutants were analyzed for immunoreactivity against Cpa or trypsin. Similar to *swd* mutants, the exocrine pancreas of the *trpm7^j124e1^* mutant is relatively small, and the acinar cells expressed Cpa ([Fig. 3A](#f3-0040240){ref-type="fig"}, upper panels). Morphometric analysis indicated that epithelial cell growth of exocrine pancreas is reduced in *trpm7^j124e1^* mutants at 3 dpf and 5 dpf ([Fig. 3B](#f3-0040240){ref-type="fig"}), and the pattern of the altered growth resembled that seen in s*wd^p75fm^* mutants ([Fig. 2B](#f2-0040240){ref-type="fig"}). Similarly, the exocrine pancreas of *trpm7^b508^* mutants was relatively small (supplementary material Fig. S1A,B) and it exhibited reduced epithelial proliferation and growth ([Table 1A](#t1-0040240){ref-type="table"}).

A complementation test by crossing *swd^p75fm^*/+ and *trpm7^j124e1^*/+ showed that the phenotype of the *swd^p75fm^*/*trpm7^j124e1^* mutants is indistinguishable from that of either *swd^p75fm^* or *trpm7^j124e1^* mutants. About 25% of the progeny larvae (*swd^p75fm^*/*trpm7^j124e1^*) exhibited reduced skin pigment and a relatively small exocrine pancreas, as observed by using trypsin and Cpa as markers of acinar cells ([Fig. 3A,C](#f3-0040240){ref-type="fig"}). The same results were obtained by crossing *swd^p82mf^*/+ and *trpm7^j124e1^*/+ (data not shown). The non-complementation between the *swd*/+ and *trpm7^j124e1^*/+ heterozygotes argues against the possibilities that the *swd*- and *trpm7*-encoded proteins are different effectors that act in the same signaling pathway, or that the *swd* and *trpm7* loci are different genes that are closely located near each other. Taken together, the data of genetic mapping, analysis of exocrine pancreas in the *swd* and *trpm7^tct^* mutants, and complementation testing strongly support that the *swd^p75fm^* and *swd^p82mf^* loci are allelic with *trpm7^j124e1^* and *trpm7^b508^*, and *trpm7* is the gene affected by the *swd* mutations.

To verify that *trpm7* is the gene responsible for the exocrine pancreatic defects of the *swd* mutants, a loss-of-function approach was employed by using morpholino antisense oligonucleotides (MOs) (*trpm7*-ATG-MO) to inhibit translation of *trpm7* mRNA, and another MO directed against the junction between exon 12 and intron 12 of the *trpm7* gene (*trpm7*-E/I-MO) to interfere with splicing of intron 12 and result in a frameshift and a premature stop codon ([@b14-0040240]). In the *trpm7*-ATG-MO-injected larvae, both the size of exocrine pancreas and the area of skin pigmentation were reduced, resembling the phenotype of the *swd^p75fm^* mutant ([Fig. 4A](#f4-0040240){ref-type="fig"}). Moreover, the pancreatic acini were relatively small and hypomorphic ([Fig. 4B](#f4-0040240){ref-type="fig"}). The proportion of epithelia in the S phase of the cell cycle and the cell size of pancreatic epithelia were also significantly reduced ([Fig. 4C,D](#f4-0040240){ref-type="fig"}). Similarly, injection of *trpm7*-E/I-MO into WT embryos produced a relatively small exocrine pancreas resembling that in the *swd* and *trpm7* mutants (supplementary material Fig. S2). These results further support that *trpm7* is the gene responsible for the exocrine pancreas and skin pigment phenotype caused by the *swd* mutations, and Trpm7 is functionally required for epithelial proliferation that is coordinately regulated with morphogenesis and growth of exocrine pancreas.

![**The *swd* locus is allelic with the *trpm7* gene.** (A) Exocrine pancreas of WT, the *trpm7^j124e1^* mutant, the *swd^p75fm^*/*trpm7^j124e1^* mutant and the *swd^p75fm^* mutant on 5 dpf by immunohistochemistry using anti-Cpa antibodies followed by cross-sectional histological analysis. Staining with DAPI was used to visualize the nuclei. The histological sections are oriented as indicated: d, dorsal; v, ventral; r, right; l, left. (B) Morphometric analysis of exocrine pancreatic epithelial growth (area, in μm^2^, per cell) in the *trpm7^j124e1^* mutants and WT siblings on 3 and 5 dpf. Each value represents the mean + s.e.m. Statistical analysis was performed using Student's *t*-test, with \**P*\<0.05 considered statistically significant. (C) Bright-field images in right lateral view and whole-mount in situ hybridization using anti-*trypsin* riboprobes. The *swd^p75fm^*/+ and *trpm7^j124e1^*/+ heterozygotes were crossed with each other, and the progeny larvae were analyzed on 5 dpf. The WT, but not mutant, larvae were grown in medium supplemented with PTU, which inhibits skin pigmentation, in order to facilitate visualization of the exocrine-pancreas-expressing trypsin. Note the regions of skin pigmentation (green arrowheads) and *trypsin*-expressing exocrine pancreas (red arrows) in the mutants as compared to WT.](DMM004564F3){#f3-0040240}

Supplementary Mg^2+^ partially rescues the exocrine pancreatic defects of *trpm7* mutants by improving cell division and cell growth
------------------------------------------------------------------------------------------------------------------------------------

The role of Trpm7 in cellular Mg^2+^ homeostasis suggests that Mg^2+^ transport is impaired in *swd* mutants. This raises the possibility that the *swd* mutation disrupts the function of Trpm7 in controlling cellular influx of Mg^2+^, resulting in reduced exocrine pancreatic epithelial proliferation. To determine whether supplementary Mg^2+^ complements the exocrine pancreatic defect of the *trpm7* mutants, the *swd^p75fm^* and *trpm7^b508^* mutant embryos, as well as their WT siblings, were incubated in medium with or without added MgCl~2~, and the exocrine pancreas was examined by in situ hybridization using anti-trypsin riboprobes. As shown in [Fig. 5A](#f5-0040240){ref-type="fig"} and supplementary material Fig. S1C,D, respectively, there was partial improvement in the size of exocrine pancreas of the *swd^p75fm^* and *trpm7^b508^* mutants when MgCl~2~ was present. There is no distinguishable difference in the size of exocrine pancreas of WT larvae grown in the presence or absence of supplementary Mg^2+^ (N.S.Y., unpublished). This suggests that the *swd^p75fm^* and *trpm7^b508^* mutations impair the function of Trpm7 in controlling the cellular Mg^2+^ level, resulting in reduced size of exocrine pancreas.

The complementary effect of Mg^2+^ on the *swd^p75fm^* and *trpm7^b508^* mutants was further evaluated for the proliferative ability of the exocrine pancreatic epithelia. Cell-cycle progression in the *swd^p75fm^* and *trpm7^b508^* mutants was significantly improved when grown in the presence of supplementary Mg^2+^, as indicated by the proportion of cells in S phase \[% BrdU-positive (+) nuclei\], as compared with those grown in E3 medium without supplementary Mg^2+^ ([Fig. 5B](#f5-0040240){ref-type="fig"}; [Table 1B](#t1-0040240){ref-type="table"}). Supplementary Mg^2+^ had no significant effect on the proportion of cells in S phase in the exocrine pancreas of WT larvae. Besides, supplementary Mg^2+^ significantly improved epithelial growth in the exocrine pancreas of the *swd^p75fm^* and *trpm7^b508^* mutants, relative to those grown without supplementary Mg^2+^ ([Fig. 5C](#f5-0040240){ref-type="fig"}; [Table 1B](#t1-0040240){ref-type="table"}). Again, supplementary Mg^2+^ had no significant effect on the growth of the exocrine pancreatic epithelia in WT larvae. These data indicate that supplementary Mg^2+^ complements the exocrine pancreas defects of the *swd^p75fm^* and *trpm7^b508^* mutants by improving cell-cycle progression and epithelial growth.

To further characterize the effect of supplementary Mg^2+^ on exocrine pancreatic epithelial proliferation in *swd^p75fm^* mutants, expression of the cyclin-dependent kinase inhibitor *p21^cdkn1a^* and *cyclin G1*, which play crucial roles in the progression from G1 to S phase (el Diery et al., 1994; [@b54-0040240]), was examined. Consistent with the defect in progression into S phase, the mRNA levels of both *p21^cdkn1a^* and *cyclin G1* were elevated in the *swd^p75fm^* mutants as compared with the WT siblings (at 0 mM supplementary Mg^2+^; [Fig. 5D,E](#f5-0040240){ref-type="fig"}; supplementary material Table S1A, gene \#25). In agreement with its complementary effect on the exocrine pancreas, addition of supplementary Mg^2+^ in the medium downregulated *p21^cdkn1a^* and *cyclin G1* mRNA expression in the *swd^p75fm^* mutants to levels close to those of WT larvae (at 20 or 40 mM supplementary Mg^2+^; [Fig. 5D,E](#f5-0040240){ref-type="fig"}). These data suggest that the *swd* mutation perturbs the function of Trpm7 in regulating cellular Mg^2+^ levels, causing upregulation of *p21^cdkn1a^* and *cyclin G1* mRNA and leading to impaired growth of exocrine pancreas.

###### 

The exocrine pancreas of *trpm7^b508^* mutants is relatively small, and the proliferative defect can be improved by supplementary Mg^2+^ or by antisense knockdown of *socs3a*

![](DMM004564T1)

The Mg^2+^-sensitive Socs3a pathway mediates the proliferative role of Trpm7
----------------------------------------------------------------------------

To gain insight into the mechanism by which supplementary Mg^2+^ improves the exocrine pancreatic phenotype, the *swd^p75fm^* mutants and their WT siblings were incubated in the absence (--) or presence (+) of added 40 mM MgCl~2~ and analyzed by transcriptional profiling. In the *swd^p75fm^* mutants (+Mg^2+^), expression of the negative modulator of epidermal growth factor (Egf)-induced proliferation, *socs3a*, was downregulated by 187% as compared with the *swd^p75fm^* mutants (--Mg^2+^) (supplementary material Table S2A, gene \#5), and this was confirmed by real-time PCR ([Fig. 6A](#f6-0040240){ref-type="fig"}). Similarly, the *socs3a* mRNA level was repressed by supplementary Mg^2+^ in the *trpm7^b508^* mutants, as compared with that in the *trpm7^b508^* mutants incubated without supplementary Mg^2+^ (supplementary material Fig. S1E). Expression of *socs3a* was verified to be upregulated in the *swd^p75fm^* mutants and *trpm7^b508^* mutants relative to WT (all incubated in E3 medium without supplementary Mg^2+^), as indicated by real-time PCR ([Fig. 6B](#f6-0040240){ref-type="fig"}; supplementary material Table S3, Fig. S1E). These data strongly suggest that Mg^2+^-modulated expression of *socs3a* mRNA is involved in the proliferative effect of Trpm7.

SOCS3 is a negative regulator of mitogenic signals, such as those induced by EGF ([@b20-0040240]), and of proinflammatory signals, such as those induced by interleukin 6 (IL-6), IL-1β, tumor necrosis factor-α and transforming growth factor-β1 (TGFβ1), in mammalian pancreatic epithelia ([@b40-0040240]; [@b52-0040240]). To determine the role of Socs3a signaling in Trpm7-mediated epithelial proliferation in exocrine pancreas, the effect of antisense knockdown of *socs3a* was analyzed. Targeted depletion of Socs3a using MO directed against the translation start site of *socs3a* mRNA partially improved growth of exocrine pancreas in *swd^p75fm^* and *trpm7^b508^* mutants. Relative to the control-MO-injected *swd^p75fm^* mutants, the exocrine pancreas of the *swd^p75fm^* mutants injected with *socs3a* MO was slightly increased in size ([Fig. 6C](#f6-0040240){ref-type="fig"}). The proportion of cells in the S phase (% BrdU+ nuclei) and cell growth (area per cell) significantly increased in the *socs3a*-MO-injected *swd^p75fm^* and *trpm7^b508^* mutants as compared with the control-MO-injected mutants ([Fig. 6D,E](#f6-0040240){ref-type="fig"}; [Table 1C](#t1-0040240){ref-type="table"}). Therefore, Socs3a is involved in modulating the proliferative role of Trpm7 in exocrine pancreatic epithelia. Taken together, results of this study suggest that Trpm7 regulates epithelial proliferation and morphogenesis of exocrine pancreas via the Mg^2+^-sensitive, Socs3a-mediated signaling pathway.

![**Antisense inhibition of zebrafish *trpm7* expression phenocopies the *swd* mutation.** (A) Bright-field images (right lateral view) and whole-mount in situ hybridization using anti-*trypsin* riboprobes (viewed in the dorsoventral direction) at 96 hpf. Note the region of pigmented skin (green arrows) and trypsin-expressing exocrine pancreas (red arrows) in the *trpm7*-ATG-MO-injected larvae as compared with the control. For in situ hybridization, the control-MO-injected embryos were grown in medium supplemented with PTU, which inhibits skin pigmentation, in order to facilitate visualization of the trypsin-expressing exocrine pancreas. This experiment was performed three times, with 25 embryos being injected for each group in each experiment. About 80--90% of larvae in each experiment exhibit the phenotype shown. The residual skin pigmentation is probably due to incomplete knockdown of *trpm7* by the MO. (B) Acinar size and morphology revealed by immunohistochemistry using anti-Cpa or anti-cadherin (Cad) antibodies, followed by histological analysis at 96 hpf. Staining with DAPI was used to visualize the nuclei. The histological sections are oriented as indicated: d, dorsal; v, ventral; r, right; l, left. (C) Proportion of exocrine pancreatic epithelia in the S phase of the cell cycle (% BrdU+ nuclei) at 72 hpf. (D) Pancreatic epithelial cell growth (area in μm^2^ per cell) by morphometric analysis at 96 hpf. Each value represents the mean + s.d. \**P*\<0.05 indicates statistically significant difference.](DMM004564F4){#f4-0040240}

![**Supplementary Mg^2+^ partially rescues the growth defect of exocrine pancreas in *swd* mutants by improving cell-cycle progression and cell growth, with repression of *p21^cdkn1a^* and *cyclin G1***. Exocrine pancreas of the *swd^p75fm^* mutants and WT siblings incubated in medium with or without supplementary 20 mM or 40 mM MgCl~2~ was analyzed. The *swdp^75fm^* mutants were identified on the basis of their hypopigmented skin, which was minimally affected by the supplementary MgCl~2~. (A) Exocrine pancreas (red arrows) in the larvae of 5 dpf embryos by in situ hybridization using anti-*trypsin* riboprobes. The WT embryos were grown in medium supplemented with PTU, which inhibits skin pigmentation and facilitates visualization of the *trypsin*-expressing exocrine pancreas. Each larva shown is representative of 40 larvae in each experimental group, and this experiment was performed three times with similar results. (B) Proliferation assay to determine the proportion of BrdU+ nuclei (cells in S phase) in the exocrine pancreas at 72 hpf. (C) Morphometric analysis of exocrine pancreatic cell growth (area, in μm^2^, per cell) at 5 dpf. Each value represents the mean of five larvae + s.d. \**P*\<0.05 is considered statistically significant. NS, not statistically significant. (D,E) Relative mRNA levels of *p21^cdkn1a^* and *cyclin G1* by quantitative real-time PCR at 5 dpf. Each value represents the ratio of *p21^cdkn1a^* or *cyclin G1* mRNA in the *swd* mutants to WT in the same experimental group. This experiment was repeated with reproducible results.](DMM004564F5){#f5-0040240}

TRPM7 is overexpressed in human pancreatic adenocarcinoma and is required for Mg^2+^-dependent cellular proliferation
---------------------------------------------------------------------------------------------------------------------

Developmental regulators of exocrine pancreas have been shown to play important roles in pancreatic carcinogenesis ([@b47-0040240]; [@b46-0040240]). To test the hypothesis that TRPM7 plays a functional role in pancreatic adenocarcinoma, expression of TRPM7 was analyzed in human pancreatic adenocarcinoma tissues by immunohistochemistry. In contrast to the low level of immunoreactivity at the apical plasma membrane of pancreatic ductal epithelia, TRPM7 was diffusely expressed in the cytoplasm at elevated levels in pancreatic adenocarcinoma ([Fig. 7A](#f7-0040240){ref-type="fig"}). Expression of *TRPM7* mRNA was then quantified in a panel of established and characterized cell lines by real-time PCR. As compared with human pancreatic ductal epithelia, *TRPM7* mRNA was expressed at elevated levels in five of seven human pancreatic adenocarcinoma cell lines examined ([Fig. 7B](#f7-0040240){ref-type="fig"}). TRPM7 protein was similarly expressed at relatively high levels in those cell lines, as revealed by immunoblot analysis (N.S.Y., unpublished). Taken together, these data indicate that TRPM7 is overexpressed in human pancreatic adenocarcinoma and suggest a functional role of TRPM7 in the pathogenesis of pancreatic neoplasia.

To determine the functional role of TRPM7 in pancreatic cancer, the effect of small interfering RNA (siRNA)-induced silencing of *TRPM7* on cellular proliferation, cell-cycle progression and apoptosis was determined. PANC-1 and BxPC-3 cells transfected with siRNA directed against *TRPM7* expressed a 70% reduced level of *TRPM7* mRNA as indicated by real-time PCR. TRPM7 protein levels were similarly reduced in the anti-*TRPM7*-siRNA-treated cells, as compared with that in the control-siRNA-treated cells, as shown by immunoblot analysis (N.S.Y., unpublished). Morphological examination revealed the presence of multinucleated cells and cytoplasmic vacuoles in both PANC-1 and BxPC-3 cells treated with anti-*TRPM7* siRNA ([Fig. 7C](#f7-0040240){ref-type="fig"}), and these features are consistent with arrest in cell division.

![**The Mg^2+^-sensitive Socs3a pathway is involved in the proliferative defect of the *swd* mutants.** Supplementary Mg^2+^ improves the exocrine pancreas phenotype of the *swd* mutants that have repression of *socs3a*. (A) *swd^p75fm^* mutants were incubated in E3 medium with or without supplementary 40 mM MgCl~2~ for 72 or 96 hpf and analyzed for *socs3a* mRNA by real-time PCR. (B) *swd^p75fm^* mutants and WT were incubated in E3 medium (containing 1.65 mM Mg^2+^) for 72 or 96 hpf, and the *socs3a* mRNA levels were determined by real-time PCR. (C) Embryos collected from *swd^p75fm^*/+ intercross were microinjected with *socs3a*-ATG-MO or control MO, incubated until 4 dpf and the exocrine pancreas (red arrows) was analyzed by whole-mount in situ hybridization using anti-*trypsin* riboprobes. The image is representative of 20 larvae in each group from three independent experiments. The *swd^p75fm^* mutants injected with either non-targeting control MO or *socs3a*-5-mispair MO are indistinguishable in the exocrine pancreas by in situ hybridization using anti-*trypsin* riboprobes. (D) *socs3a*-ATG-MO- or control-MO-injected larvae were incubated until 72 hpf, injected with BrdU and then analyzed for the proportion of cells in S phase (% BrdU+ nuclei). (E) *socs3a*-ATG-MO- or control-MO-injected larvae were incubated until 96 hpf and analyzed for cell growth (area, in μm^2^, per cell). \**P*\<0.05 indicates statistically significant difference. (C-E) The *swd^p75fm^* mutants were identified on the basis of their hypopigmented skin, which was not grossly affected by *socs3a*-ATG-MO.](DMM004564F6){#f6-0040240}

As compared with control-siRNA-treated cells, proliferation of the TRPM7-deficient cells was significantly reduced (by 32%) as measured by the MTS assay, and reduced by 36% as determined by counting viable cells ([Fig. 8A](#f8-0040240){ref-type="fig"}). Flow cytometric analysis of cell cycle indicated an increase in the proportion of TRPM7-deficient cells in G0--G1 phases by 42% compared with controls, and a reduced proportion of cells in the S and G2-M phases by 32% and 17%, respectively ([Fig. 8B](#f8-0040240){ref-type="fig"}). No significant change in the proportion of apoptotic cells or the level of the proapoptotic protein BAX by treatment of anti-*TRPM7* siRNA was observed (N.S.Y., unpublished). Analysis of the cell-cycle regulators in the TRPM7-deficient BxPC-3 and PANC-1 cells by real-time PCR revealed an increase of *p21^CDKN1A^* mRNA levels, and a decrease of cyclin G1 and cyclin B1 mRNA levels ([Fig. 8C](#f8-0040240){ref-type="fig"}). These findings indicate that TRPM7 is required for cellular proliferation of pancreatic adenocarcinoma by regulating transition from G1 to S and G~2~ to M in the cell division cycle.

The complementary effect of Mg^2+^ on the exocrine pancreatic defect of the zebrafish *swd* mutants is consistent with the role of TRPM7 in cellular Mg^2+^ homeostasis. To determine the role of Mg^2+^ in TRPM7-mediated proliferation of pancreatic cancer cells, TRPM7-deficient PANC-1 and BxPC-3 cells were incubated in culture medium in the presence or absence of 1 mM MgSO~4~, and then analyzed for proliferation. In the absence of supplementary Mg^2+^, proliferation was significantly reduced (by 37% and 35%) as indicated by the MTS assay and counting cells, respectively ([Fig. 8D](#f8-0040240){ref-type="fig"}). In the presence of supplementary Mg^2+^, proliferation of the TRPM7-deficient cells was restored to the same levels as in the cells transfected with non-targeting control siRNA ([Fig. 8D](#f8-0040240){ref-type="fig"}). These results indicate an essential role of Mg^2+^ in TRPM7-mediated control of proliferation in pancreatic adenocarcinoma cells, and they further support the idea that TRPM7 controls cellular influx of Mg^2+^ or, alternatively, that Mg^2+^ modulates TRPM7-mediated signaling.

Discussion
==========

The roles of ion channels in exocrine pancreatic development and oncogenesis are mostly unknown. Using zebrafish as a vertebrate model organism, we have presented evidence that the ion channel-kinase Trpm7 controls the size of exocrine pancreas during embryogenesis by regulating cell division and cell growth. Results of this study reveal that Mg^2+^-sensitive Socs3a signaling modulates the proliferative role of Trpm7 in exocrine pancreas. The findings in zebrafish can be translated into human pancreatic adenocarcinoma, in which TRPM7 is overexpressed and required for Mg^2+^-dependent proliferation of the cancer cells. We hypothesize that Trpm7 contributes to the homeostatic mechanism that controls the size of exocrine pancreas in vertebrates, and suggest that TRPM7-mediated signaling can be further evaluated as diagnostic and/or prognostic biomarkers and therapeutic targets in human pancreatic adenocarcinoma.

![**TRPM7 is overexpressed in human pancreatic adenocarcinoma and required for cellular proliferation.** (A) Expression of TRPM7 protein in human pancreatic adenocarcinoma (upper panel) and normal pancreatic tissue (lower panel) by immunohistochemistry using anti-TRPM7 antibodies. The images shown are representative of five tumor specimens and five normal control samples. Scale bars: 100 μm. (B) Relative *TRPM7* mRNA levels in human pancreatic adenocarcinoma cell lines by quantitative real-time PCR. Each value represents the mean ratio of each pancreatic cancer cell line to that of H6c7 from triplicate samples, and reproducible results were obtained from two independent experiments. (C) Cell morphology at 24 hours post-transfection with siRNA was examined under an inverted microscope with phase contrast. Red arrows point to multinucleated cells with cytoplasmic vacuoles.](DMM004564F7){#f7-0040240}

Trpm7 regulates exocrine pancreatic epithelial proliferation and morphogenesis
------------------------------------------------------------------------------

TRPM7 is ubiquitously expressed in mammals ([@b17-0040240]) and zebrafish (<http://zfin.org>), yet loss-of-function mutations in *trpm7* produce organ-specific phenotypes. In zebrafish, Trpm7 is functionally required for survival of melanophores: disruption of *trpm7* by the *trpm7^j124e1^*, *trpm7^b508^* or *swd* mutations, or by targeted knockdown using MO, diminishes skin pigmentation and depletes melanophores ([@b30-0040240]; [@b9-0040240]; [@b4-0040240]; [@b14-0040240]; [@b47-0040240]; [@b27-0040240]) (this study). Furthermore, it has been shown that the zebrafish *tct*/*trpm7^j124e1^* and *nutria*/*trpm7^j124e2^* mutations impair skeletal development, which is associated with nephrolithiasis and impeded growth ([@b14-0040240]). Although global deletion of the *Trpm7* gene in mouse is embryonically lethal, selective disruption of *Trpm7* in developing thymocytes causes loss of thymic architecture and a reduced number of T cells ([@b21-0040240]). In this study and our previous report ([@b47-0040240]), analyses of the *swd*, *trpm7^j124e1^* and *trpm7^b508^* mutants and the morphants with disrupted expression of *trpm7* support the functional role of Trpm7 in regulating epithelial cell-cycle progression and growth and, consequently, acinar and ductal morphogenesis. It is interesting to note that global analysis reveals elevated expression of *p21^cdkn1a^*, *cyclin G1* and *socs3a* in *swd* mutants. The relatively specific phenotype in the exocrine pancreas and skin pigmentation might be related to the specific requirement of different tissues, timing of expression and molecular context. However, recent evidence suggests that a developmentally established intrinsic program limits the number of embryonic progenitor cells in the mouse pancreas and determines the organ size ([@b36-0040240]). In light of those findings, we hypothesize that Trpm7 is involved in the homeostatic mechanism that regulates proliferation of exocrine pancreatic progenitor cells and controls the growth and thus the size of exocrine pancreas during embryonic development.

![**TRPM7 controls cellular proliferation by regulating cell-cycle progression and by modulating *p21^CDKN1A^*, *cyclin G1* and *cyclin B1* expression and Mg^2+^ level.** (A) PANC-1 cells were treated with siRNA directed against *TRPM7*, non-targeting control siRNA, or without siRNA, and then analyzed by MTS assay and counting cells. Proliferation in the anti-*TRPM7-*siRNA-treated cells is represented as percent of that in the cells treated with non-targeting control siRNA. Each column represents the mean from triplicate samples. Bars represent s.d. \**P*\<0.05 indicates statistical significance. (B) Cell cycle at 72 hours following transfection with siRNA was determined by flow cytometric analysis of DNA content. The proportion of cells in each phase of the cell cycle is indicated. (C) Total RNA was extracted from BxPC-3 and PANC-1 cells at 72 hours following transfection with anti-*TRPM7* or non-targeting control siRNA, and analyzed for *p21^CDKN1A^*, *cyclin G1* and *cyclin B1* mRNA by quantitative real-time PCR. Each column represents the mean from triplicate samples in TRPM7-deficient cells as % of that in control-siRNA-transfected cells. Similar results were obtained from at least two independent experiments. (D) Proliferation assay of PANC-1 cells transfected with anti-*TRPM7* siRNA or non-targeting control siRNA, incubated in culture medium with or without added 1 mM MgSO~4~ for 72 hours by measuring MTS absorbance or counting viable cells. Bars represent s.d. \**P*\<0.05; NS, not statistically significant.](DMM004564F8){#f8-0040240}

The molecular nature of the *swd* mutations in the *trpm7* gene remains to be identified; however, this study provides evidence that the kinase domain and the C-terminal sequence of Trpm7 is required for normal growth of exocrine pancreas. This is supported by the data showing the relatively small exocrine pancreas and the reduced epithelial cell division and growth in *trpm7^j124e1^* and *trpm7^b508^* mutants. Electrophysiological studies in mammalian cells with heterologously expressed kinase-deficient TRPM7 suggest that TRPM7 kinase activity is not necessary for channel activation but is important for sensitivity of the channel to Mg^2+^ ([@b35-0040240]). Results of another study indicate that the channel function of TRPM7 is not dependent on its kinase activity or autophosphorylation, and they suggest that the kinase domain is structurally necessary for the channel activity of TRPM7 ([@b26-0040240]). In light of those studies and the defects observed in the *trpm7^j124e1^* and *trpm7^b508^* mutants ([@b14-0040240]; [@b27-0040240]) (this study), we hypothesize that the kinase domain of Trpm7 is required for its functional role in normal development. Whether the *swd* mutations produce the skeletal defects of the *trpm7^j124e1^* adult mutants remains to be determined. Further studies should directly determine the role of channel activation and kinase activity of Trpm7 in pancreatic epithelial proliferation and growth of exocrine pancreas. Moreover, future gain-of-function studies by overexpressing *trpm7* under an exocrine-pancreas-specific promoter such as that of the *ptf1a* or *elastase* gene in WT or a zebrafish line with a mutation in *K-ras* or *p53* are expected to help define the role of Trpm7 in pancreatic growth.

Mg^2+^-sensitive Socs3a pathway links Trpm7 to growth-factor and cytokine-induced signaling
-------------------------------------------------------------------------------------------

This study reveals a mechanism that modulates the proliferative role of Trpm7 in exocrine pancreas by the Mg^2+^-sensitive Socs3a pathway. Mg^2+^ is considered a key factor that coordinates control of cell proliferation ([@b31-0040240]; [@b41-0040240]) and is involved in receptor-mediated mitogenic signals of growth factors ([@b44-0040240]). Consistent with the role of Trpm7 in cellular Mg^2+^ homeostasis, the exocrine pancreatic defect of the *swd* and *trpm7^b508^* mutants can be partially rescued by supplementary Mg^2+^. Similarly, the rescue effect of supplementary Mg^2+^ on melanophores has also been demonstrated in *tct*/*trpm7^j124e1^* mutants ([@b14-0040240]; [@b27-0040240]). These findings suggest that the *swd* and *trpm7^j124e1^* mutations perturb cellular Mg^2+^ homeostasis, such that supplementary Mg^2+^ restores the cellular balance of Mg^2+^. Alternatively, supplementary Mg^2+^ might activate the signaling pathways downstream of Trpm7 in the mutants. However, Mg^2+^-mediated rescue is partial, possibly because a high concentration of Mg^2+^ in the medium is cardiotoxic. Evidence for this is that, in the larvae incubated at 50 mM and 100 mM MgCl~2~, generalized edema is observed beginning at 4 dpf and it became prominent at 5 dpf and afterwards (N.S.Y., unpublished).

Transcriptional profiling of *swd* mutants incubated in the absence or presence of supplementary Mg^2+^ has begun to elucidate the signaling pathways that mediate the developmental role of Trpm7 in exocrine pancreas. As shown in this study, the negative regulator of growth-factor and cytokine signaling, Socs3a, is involved in the Mg^2+^-sensitive proliferative action of Trpm7. Recent evidence from targeted deletion of *Trpm7* in mice has indicated that signal transducers and activators of transcription 3 (STAT3), which is negatively regulated by SOCS3, is involved in TRPM7-mediated signaling during lymphocytic development ([@b21-0040240]). In agreement with the elevated level of *socs3a* mRNA in the *swd*/*trpm7* mutants in our study, disrupted expression of *Trpm7* in mice causes downregulated expression of *Stat3* mRNA ([@b21-0040240]). Indeed, repression of *STAT3* decreases proliferation of a variety of cell types, including in pancreatic cancer cells ([@b23-0040240]; [@b34-0040240]). Thus, the involvement of Socs3a (this study) and STAT3 ([@b21-0040240]) links TRPM7 to the signaling pathways that mediate the mitogenic effects of growth factors and the proinflammatory effects of cytokines. Besides, expression of the developmental pathways known to play important roles in exocrine pancreas, including Hedgehog, Notch, Wnt, Tgfβ and Fgf, is altered in *swd^p75fm^* mutants (supplementary material Table S3). Ongoing studies are focused on determining how these developmental pathways influence expression of *socs3a* and the other proinflammatory genes in the *swd*/*trpm7* mutants as well as in human pancreatic adenocarcinoma cells incubated in the absence or presence of supplementary Mg^2+^. These data are expected to help understand the mechanism that mediates the functional roles of Trpm7 and Mg^2+^ in exocrine pancreatic epithelial proliferation and morphogenesis.

Potential role of TRPM7 in the pathogenesis of pancreatic cancer
----------------------------------------------------------------

In our attempt to translate the developmental studies of Trpm7 in zebrafish to human disease, we identified a functional role of TRPM7 in human pancreatic cancer. This finding is supported by the global genomic analysis of gene expression in human pancreatic adenocarcinoma tissues and cell lines ([@b22-0040240]). Detailed examination of the level and pattern of TRPM7 expression in normal pancreatic ductal and acinar epithelia, intraepithelial neoplasia, and invasive adenocarcinoma is ongoing and is expected to provide further insights into its role in the initiation and progression of pancreatic tumors.

Moreover, TRPM7 is required for proliferation of the cancer cells as evidenced by the cellular assays and modulation of the cell-cycle regulators, and TRPM7-mediated proliferation of pancreatic adenocarcinoma cells is Mg^2+^-dependent. These findings are consistent with and complementary to the zebrafish loss-of-function studies of Trpm7 and Mg^2+^-mediated rescue in the developing exocrine pancreas. The upregulated expression of *p21^CDKN1A^* and repression of cyclin B1 in TRPM7-deficient pancreatic adenocarcinoma cells are consistent with the observed reduction of the proportions of cells in the S and G2-M phases. It is interesting to note that cyclin G1 expression is downregulated in the pancreatic cancer cells that had reduced expression of *TRPM7*, suggesting a growth-promoting activity of cyclin G1. By contrast, supplementary Mg^2+^-mediated partial rescue of the exocrine pancreatic defect in the zebrafish *swd* mutants is associated with repression of *cyclin G1*, suggesting a growth-inhibitory activity of cyclin G1. The apparently conflicting roles of cyclin G1 in growth control have also been noted by others and might be at least partially explained by the intrinsic growth-suppressing activity of cyclin G1 being dependent on its expression level ([@b54-0040240]). However, the findings of this study together with the established role of TRPM7 in cation transport strongly indicate a physiological role of TRPM7 and Mg^2+^ and Ca^2+^ in pancreatic ductal epithelia, and suggest that aberrant TRPM7-mediated signals contribute to uncontrolled proliferation of neoplastic cells.

Conclusion and prospective
--------------------------

Genetic studies of the zebrafish *swd* and *trpm7* mutants, and expression analysis of TRPM7 in human pancreatic adenocarcinoma -- as well as experiments of silencing the *trpm7* gene in zebrafish larvae and in human pancreatic cancer cells --provide evidence that TRPM7 is functionally required for pancreatic epithelial proliferation. These findings suggest that Trpm7 and/or Mg^2+^ and the associated Socs3a signaling play an important role in the homeostatic mechanisms that control the number of pancreatic progenitors and determine the size of exocrine pancreas during development. Moreover, aberrant TRPM7-mediated signaling might be involved in the uncontrolled cellular proliferation during formation of pancreatic neoplasia. Ongoing studies focus on determining the signaling mechanisms that mediate the functional role of TRPM7 in exocrine pancreatic growth during vertebrate morphogenesis and the tumorigenic process, and on exploring TRPM7 as a diagnostic and/or prognostic biomarker and a therapeutic target in human pancreatic adenocarcinoma.

METHODS
=======

Zebrafish stock
---------------

Zebrafish husbandry is described in detail elsewhere ([@b6-0040240]). The *swd^p75fm^* and *swd^p82mf^* mutant lines were described previously ([@b47-0040240]). WT zebrafish of the AB strain and the *trpm7^j124e1^* mutant line were obtained from the Zebrafish International Resource Center (Portland, OR). The *trpm7^b508^* mutant embryos were provided by Gregory Bonde (Laboratory of Robert Cornell) at the University of Iowa. The E3 embryo medium contains 5 mM NaCl, 0.17 mM KCl and 1.65 mM MgSO~4~. To facilitate visualization of exocrine pancreas in the larvae, 1-phenyl-2-thiourea (PTU; Sigma) was added to E3 medium at 0.003% to inhibit skin pigmentation as indicated. For supplementary Mg^2+^, a stock solution of 1 M MgCl~2~ hexahydrate (Sigma-Aldrich) was prepared in purified water (Milli-Q Synthesis, Millipore Corporation, Billerica, MA) and diluted at the indicated concentrations with E3 medium.

Immunohistochemistry, in situ hybridization, and histological analysis
----------------------------------------------------------------------

These procedures are essentially as described ([@b47-0040240]; [@b47-0040240]). For immunohistochemistry, rabbit anti-Cpa antibodies (Rockland Immunochemicals), mouse anti-BrdU antibodies (Roche), guinea pig anti-insulin and anti-glucagon antibodies (Linco/Millipore), and rabbit anti-pan-cadherin antibodies (Sigma) were used at 1:100 dilution in 5% goat serum (Gibco/Invitrogen). For in situ hybridization, *trypsin* and *ptf1a* antisense riboprobes were prepared ([@b47-0040240]; [@b24-0040240]). Zebrafish larvae were examined under a stereo-microscope (Leica MZ16F, Plymouth, MN) with bright light. Images were captured using QImaging digital camera and Q-Capture application, and constructed using Adobe Photoshop 7.0. For histological analysis, zebrafish larvae were embedded in JB-4 Plus solution (Polysciences) and sectioned at 5-μm intervals using a semi-automatic microtome (Leica RM2255, Plymouth, MN). The immunoassayed sections were mounted with VECTASHIELD with 4′,6 diamidino-2-phenylindole (DAPI) (Vector Laboratories) and examined under a compound microscope (Olympus BX51, Tokyo, Japan) using fluorescence. The non-immunoassayed sections were stained with methylene blue (Acros)-azure II (Sigma) solution, mounted with Permount (Sigma) and examined under a compound microscope (Olympus BX51) using bright light. The images were acquired using a digital camera (Olympus DP71), analyzed using DP Manager software (Olympus) and constructed using Adobe Photoshop 7.0.

Exocrine pancreatic epithelial cell cycle
-----------------------------------------

BrdU (Sigma) was used as a cellular marker for the S phase of the cell cycle, detected by immunohistochemistry, followed by histological examination, and analysis was performed by cell counting as described ([@b47-0040240]). Briefly, each larva at 72 hpf was injected with 30 nl of 30 mM BrdU into the yolk sac under a stereo-dissecting microscope (Leica MZ16, Plymouth, MN), followed by incubation at 28.5°C for 1 hour, and then fixed with 4% paraformaldehyde. For immunohistochemistry, the larvae were permeabilized with proteinase K, treated with 3 N hydrochloric acid to denature the double strands of DNA, and washed with phosphate buffered saline, pH 7.0, with 0.1% Tween 20 (PBS-T). Mouse anti-BrdU antibodies were added at 1:100 dilution for incubation at 4°C overnight. Guinea pig anti-insulin and anti-glucagon antibodies (Linco/Millipore) were also added at 1:100 dilution as markers of pancreatic islet cells. Following incubation, the larvae were washed with PBS-T, and then incubated with Alexa-Fluor-488-conjugated goat anti-mouse IgG and Alexa-Fluor-594-conjugated goat anti-guinea-pig IgG (Invitrogen). Following incubation at 4°C overnight, the larvae were washed with PBS-T, serially dehydrated with ethanol and embedded with JB-4 plastic solution (Polysciences). The embedded larvae were cross-sectioned at 5-μm intervals and analyzed. Five larvae in each group were evaluated, and for each larva three sections containing exocrine pancreas posterior to the last section of islet were analyzed. For each larva, the number of DAPI-positive nuclei, number of BrdU-positive nuclei, and proportion of DAPI-positive nuclei being BrdU-positive and representing the percentage of cells in the S phase, were determined.

Exocrine pancreatic epithelial growth
-------------------------------------

Morphometric analysis of cell growth was performed using cadherin as a marker of intercellular junctions. Larvae were fixed with methanol/dimethyl sulfoxide (80:20) as described ([@b47-0040240]).

Cadherin was detected by immunohistochemistry using rabbit anti-pan-cadherin antibodies (Sigma) at 1:100 dilution. Guinea pig anti-glucagon antibodies (Linco/Millipore) were added at 1:100 dilution as markers of pancreatic islet cells. The immunoassayed larvae were embedded and cross-sectioned at 5-μm intervals. Five larvae in each group were evaluated, and for each larva three sections containing exocrine pancreas posterior to the last section of islet were analyzed. The surface area of exocrine pancreas on each of three sections posterior to the last section of islet, the number of DAPI-positive nuclei, and the surface area per cell, which indicates cell growth, were determined.

Positional cloning and complementation test
-------------------------------------------

To identify the gene affected by the *swd* mutation, we collected 2500 *swd^p75fm^* mutants and isolated genomic DNA for bulked segregant analysis and high-resolution meiotic mapping as described ([@b50-0040240]). Using simple sequence repeats as genomic markers, available at <http://zfrhmaps.tch.harvard.edu/ZonRHmapper/RHLg/lg18.htm>, we have located the *swd* mutation on chromosome 18 (Manimegalai Muthumani, Michael Pack, and N.S.Y., unpublished). On the basis of four recombination events in 1222 meioses, we identified a genomic marker z25105 within 0.3 cM (estimated to be 180 kb, assuming an average of 60 kb per 0.1 cM in zebrafish) from the *swd* mutation. In this region, a gene that corresponds to the zebrafish ortholog of mammalian *TRPM7* is affected by the zebrafish mutation *tct* ([@b30-0040240]; [@b9-0040240]; [@b4-0040240]; [@b14-0040240]). The alleles of *tct* are also known as *trpm7^j124e1^* and *trpm7^b508^*. A complementation test performed by crossing *swd^p75fm^*/+ or *swd^p82mf^*/+ with *trpm7^j124e1^*/+ produced 25% of mutant larvae with indistinguishable phenotype of exocrine pancreas and skin pigmentation as the *swd^p75fm^*, *swd^p82mf^* and *trpm7^j124e1^* mutants.

Targeted gene knockdown with morpholino anti-sense oligos
---------------------------------------------------------

MO was microinjected into the embryos as described ([@b47-0040240]). Briefly, embryos were microinjected at the one-cell stage with MO (0.45 pmole in 1 nl per embryo) into the yolk sac and incubated at 28.5°C until analysis. The MOs were directed against the translation start site of zebrafish *trpm7* mRNA (*trpm7*-ATG-MO: 5′-CCAGGACTTCTGGGACATTCTCTTC-3′ based on *trpm7* cDNA sequence; GenBank accession number AY860421); the junction between exon 12 and intron 12 of the *trpm7* gene (*trpm7*-E/I-MO: 5′-GTGTGTGAGATTTACTCTGCTGTTC-3′), which interferes with splicing of intron 12 and results in a frameshift and a premature stop codon as described by Elizondo et al. ([@b14-0040240]); the translation start site of zebrafish *socs3a* mRNA (*socs3a*-ATG-MO: 5′-TGTGGGTTATCATGGCGATACACAC-3′, based on *socs3a* cDNA sequence; GenBank accession number BC049326). Gene-specific mismatch oligos including *trpm7*--5-mispair-MO (5′-CCtGcACTTgTGGcACATTgTCTTC-3′) and *socs3a*-5-mispair-MO (5′-TGTGGcTTATgATGcCGAaAgACAC-3′) (lowercase indicates mismatched bases), as well as standard control oligos (5′-CCTCTTACCTCAGTTACAATTTATA-3′) that have been shown not to be directed against any zebrafish gene sequence, were used as controls. The *trpm7*-ATG-MO, *trpm7*-E/I-MO, *trpm7*--5-mispair-MO, *socs3a*-ATG-MO, *socs3a*-5-mispair-MO and control MO were designed and produced by Gene Tools, LLC (Philomath, OR).

Semi-quantitative real-time PCR
-------------------------------

Total RNA was isolated from 20 *swd^p75fm^* mutants or their WT siblings using TRIzol (Invitrogen) and RNeasy Mini Kit (Qiagen) according to the manufacturers' instructions. First-strand cDNA was generated using SuperScript reverse transcriptase and random primers (Invitrogen) and amplified with SYBR Green (Applied Biosystems) using ABI Prism 7700 real-time PCR system (Applied Biosystems, Foster City, CA). The sequences of the primers used for analysis of expression of *p21^cdkn1a^*, *cyclin G1* and *socs3a* are based on zebrafish cDNA sequences (GenBank accession numbers: AL912410, AY423016 and BC049326, respectively) as follows: *p21^cdkn1a^*: 5′-ATGCAGCTCCAGACAGATGA-3′, 5′-CGCAAACAGACCAACATCAC-3′; *cyclin G1*: 5′-TAAGATCGCCCATCTACCTA-3′, 5′-ACCATAGTCTGAAGGCAGAA-3′; *socs3a*: 5′-GAGGGGAGAAAATCCCTCTG-3′, 5′-GCCCAAAAACGT-AAGCCATA-3′.

*Glyceraldehyde-3-phosphate dehydrogenase* (*gapdh*) was used as internal control to normalize for the amount of RNA in each sample. The primers used for amplification are based on zebrafish *gapdh* cDNA sequence (GenBank accession number BC095386): *gapdh*: 5′-GATACACGGAGCACCAGGTT-3′, 5′-CGTTGAGAGCAATACCAGCA-3′.

The conditions for quantitative PCR are as follows: 2 minutes at 50°C, 10 minutes at 95°C, followed by 40 cycles: 15 seconds at 95°C, 1 minute at 60°C, and 10 minutes at 72°C. Each sample was analyzed in triplicate, and each experiment performed three times. The mRNA levels were analyzed, and the mean ratio of *p21^cdkn1a^*, *cyclin G1* and *socs3a* mRNA to *gapdh* mRNA was determined using the Comparative C~T~ Method (Applied Biosystems). Samples of PCR using primers directed against *p21^cdkn1a^*, *cyclin G1*, *socs3a* and *gapdh* were analyzed by agarose gel electrophoresis to validate specificity of amplification products.

Transcriptional profiling
-------------------------

Twenty *swd^p75fm^* mutants or their WT siblings were incubated at 28.5°C in E3 medium with or without supplementary 40 mM MgCl~2~ for 72 hours. Total RNA was extracted using TRIzol (Invitrogen) and RNeasy Mini Kit (Qiagen) from each group of larvae. Each sample of RNA (50 ng) was converted by single primer isothermal amplification (SPIA) to cDNA using the Ovation RNA Amplification System (NuGEN Technologies). The amplified cDNA product was purified, fragmented, biotin-labeled, mixed with hybridization buffer, placed onto Affymetrix Zebrafish arrays (containing 14,900 transcripts) and incubated at 45°C for 18 hours with 60 rpm rotation. Following hybridization, the arrays were washed, stained with streptavidin-phycoerythrin (Molecular Probes/Invitrogen) and signal-amplified with anti-streptavidin antibodies (Vector Laboratories). Arrays were scanned with the Affymetrix Model 3000 scanner (Santa Clara, CA), and data were collected using the GeneChip operating software (Affymetrix). The microarray data were analyzed using analysis of variance (ANOVA) with the Partek Genomic Suite Software.

Tissues and cell cultures
-------------------------

Human pancreatic adenocarcinoma and matched normal tissues embedded in paraffin were obtained from the Tissue Procurement Core of the University of Iowa (with Institutional Review Board approval). The human pancreatic adenocarcinoma cell lines BxPC-3, Capan-1, HPAF-II, MIA PaCa-2, Panc 02.03, PANC-1 and PL45 were obtained from the American Type Culture Collection (ATCC, Manassas, VA), and maintained according to the ATCC instructions. The human pancreatic ductal epithelial cell line H6c7 was described previously ([@b18-0040240]). Cell culture media were supplemented with 10% heat-inactivated fetal bovine serum (FBS; HyClone), 100 U/ml penicillin (Gibco) and 100 μg/ml streptomycin (Gibco). Cells were grown in a humidified atmosphere containing 5% CO~2~ at 37°C. All experiments were performed using culture medium unless otherwise specified. The cells were used within 20 passages of the stocks frozen in liquid nitrogen.

Immunohistochemistry of TRPM7
-----------------------------

The paraffin-embedded tissues were sectioned at 4-μm intervals using a microtome (Leica Microm HM355S, Plymouth, MN), deparaffinized in xylene and treated with citrate buffer, pH 6, preheated in a steamer to unmask antigen. The sections were treated with 3% hydrogen peroxide to quench endogenous peroxidase activity, and then incubated with goat anti-TRPM7 antibodies (1:25; Abcam) for 60 minutes, rinsed with Tris-buffered saline and incubated with horseradish-peroxidase-conjugated anti-rabbit IgG (EnVision+ System; Dako) for 30 minutes. The signals were detected by color reaction using 3,3′-diaminobenzidine (Dako) as substrate for 5 minutes. The sections were counterstained with hematoxylin (Richard-Allan Scientific) and mounted using Permount (Sigma). Negative controls were incubated without primary antibody to rule out non-specific binding by the secondary antibody and to confirm the efficiency of blocking. The expression of TRPM7 was examined under a compound microscope (Olympus BX51). The images were captured using a digital camera (Olympus DP71), analyzed using DP Manager software (Olympus) and constructed using Adobe Photoshop 7. The images shown are representative of matched specimens from five patients.

Absolute quantification of mRNA in human cells by real-time PCR
---------------------------------------------------------------

Total RNA extracted from each cell line was analyzed using ABI Prism 7500 real-time PCR system (Applied Biosystems, Foster City, CA) essentially as described ([@b46-0040240]). The sequences of the primers used were designed based on human cDNA sequences (GenBank accession numbers: *TRPM7*, AY032950; *p21^CDKN1A^*, NM_000389; cyclin G1, AY791292; cyclin B1, BC006510) as follows: *TRPM7*: 5′-AAACCAGTTCTGCCTCCTCCAC-3′, 5′-ATTCTCCATGTCCTCGTATG-3′; *p21^CDKN1A^*: 5′-CATTTTAAGATGGTGGCAGT-3′, 5′-AGTGCCAGGAAAGACAACTA-3′; cyclin G1: 5′-GCCTGAGAAGGTAAACTGTG-3′, 5′-AAGCTGTGGGAAGACTGATA-3′; cyclin B1: 5′-TCTCCATTATTGATCGGTTC-3′, 5′-CAGTCACAAAAGCAAAGTCA-3′.

The mRNA levels were determined with a standard curve using known concentrations of mRNA of each gene.

RNA-interference-mediated gene silencing
----------------------------------------

PANC-1 and BxPC-3 were grown to 70--80% confluency, trypsinized and resuspended at 10^6^ cells in 100 μl of Nucleofector Solution (Amaxa/Lonza) containing 600 nM siRNA directed against human *TRPM7* (sc-42662; pre-made and validated by Santa Cruz Biotechnology). Transfection was based on electroporation using Nucleofector II (Amaxa/Lonza, Cologne, Germany) and performed under the optimal conditions already established for the cell line by the manufacturer and confirmed in our laboratory. For controls done in parallel, 10^6^ cells were transfected with 600 nM non-targeting control siRNA (sc-37007; Santa Cruz Biotechnology) or no siRNA. Immediately following transfection, 500 μl of pre-warmed (37°C) culture medium was added to each cuvette, and the cells transferred to a six-well plate containing 1.5 ml pre-warmed (37°C) culture medium. The siRNA-treated cells and controls were incubated at 37°C with 5% CO~2~. 48 or 72 hours following transfection, the cells were assayed for proliferation, morphology, cell cycle, apoptosis, mRNA and protein levels.

Cellular morphology
-------------------

PANC-1 and BxPC-3 cells were transfected with anti-*TRPM7* siRNA, non-targeting control siRNA or no siRNA, plated in six-well tissue-culture dishes at a density of 5×10^5^ per well, and incubated for 24 hours. Images of the cells were captured under an inverted light microscope with phase contrast (Olympus IX81, Tokyo, Japan).

Proliferation assay
-------------------

The effects of siRNA directed against *TRPM7* on cellular proliferation were quantified using the CellTiter 96 AQ~ueous~ One Solution Cell Proliferation Assay (Promega) using 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfonylphenyl)-2H-tetrazolium (MTS) as described ([@b7-0040240]). In this study, PANC-1 and BxPC-3 cells were transfected with anti-*TRPM7* siRNA or non-targeting control siRNA. The transfected cells were seeded at 2×10^4^ in 100 μl medium per well of a 96-well plate (Corning Incorporated) for MTS assay, or at 5×10^5^ in 4 ml medium per well of a six-well plate for cell counting. The cells were incubated for a total of 72 hours with fresh culture medium being replaced at the final 24 hours. Proliferation was analyzed using the MTS assay or by counting cells using trypan blue for exclusion of dead cells.

Flow cytometric analysis of cell cycle
--------------------------------------

PANC-1 and BxPC-3 cells were deprived of serum for 24 hours, then transfected with anti-*TRPM7* siRNA or non-targeting control siRNA, seeded at 5×10^5^ in 4 ml medium in each well of a six-well plate, and incubated for 72 hours. The DNA contents were analyzed by flow cytometry using a FACScan (Becton, Dickinson and Company, Franklin Lakes, NJ) using propidium iodide (Invitrogen) as described ([@b7-0040240]). Non-specific sub-G0--G1 events were gated out of analyses, allowing for more accurate analysis of cell-cycle distribution curves in the viable cells.

Flow cytometric analysis of apoptosis
-------------------------------------

PANC-1 and BxPC-3 transfected with anti-*TRPM7* or non-targeting control siRNA were incubated with fluorescein-isothiocyanate-conjugated annexin V (Invitrogen) and propidium iodide (Invitrogen) at 72 hours post-transfection, and analyzed for apoptosis by flow cytometry as described ([@b7-0040240]).

Statistical analysis
--------------------

The mean, s.d., s.e.m. and *P*-values were analyzed using the Student's *t*-test. Statistical significance was considered at a *P*-value \<0.05.
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